Purchase Order 36C24423P0435
Award Date 4/12/23
Potential Completion Date 4/11/24
Potential Value $47K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $80,260 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. This contract is not set aside for any specific...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $121,000.00 contract is for the supply of radiopharmaceuticals, including specialized medical isotopes such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223...
- This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo, to support nuclear medicine, oncology, and...
- This $955,499.55 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of radiopharmaceuticals, including specialized medical isotopes such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has an...
- This federal contract award, valued at $405,154.73, was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. These products are delivered to VA medical...
- This federal contract award, valued at $157,985.87, was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, such as technetium-99m, iodine-123, and fluorine-18 FDG, used in nuclear medicine, oncology, and diagnostic imaging services within the VA healthcare system. The contract is a delivery order under a larger Indefinite Delivery Vehicle...
- This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of radiopharmaceuticals. The contract, valued at $713,585.56, is a delivery order issued by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA). The contract has an ultimate completion date of September 30, 2024, and is structured as a firm fixed-price arrangement. This award does not have a set-aside designation, indicating Cardinal...
- This federal contract award, valued at $801,456.68, was issued by the Veterans Integrated Service Network 21 (VISN 21) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. This delivery order contract has a...
- This is a delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies such as Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has a ceiling value of $127,107.03 and a period of...
- This is a firm-fixed-price delivery order contract awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., to provide radiopharmaceuticals to the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 21. The contract has a potential value of $406,942.11 and covers the delivery of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well...